Skip to main content

Cero Therapeutics Holdings, Inc.

CERO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001870404

No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCEROW

13F holders, Q2 2022

Institutional positions in Cero Therapeutics Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+9 vs. Q1 2022
Shares held
14.4M
+703.9K (+5.1%) vs. Q1 2022
Total value
$144.5M
+$7.35M (+5.4%) vs. Q1 2022
New holders
14
12 more added
Sold out
5
5 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CERO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 54 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 36 institutionsQ1 2022: 45 institutionsQ2 2022: 54 institutionsQ3 2022: 66 institutionsQ4 2022: 46 institutionsQ1 2023: 17 institutionsQ2 2023: 13 institutionsQ3 2023: 10 institutionsQ4 2023: 10 institutionsQ1 2024: 9 institutionsQ2 2024: 15 institutionsQ3 2024: 18 institutionsQ4 2024: 21 institutionsQ1 2025: 15 institutionsQ2 2025: 8 institutionsQ3 2025: 11 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $144.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $104.2MQ1 2022: $137.2MQ2 2022: $144.5MQ3 2022: $153.0MQ4 2022: $101.1MQ1 2023: $12.5MQ2 2023: $10.6MQ3 2023: $7.33MQ4 2023: $7.49MQ1 2024: $4.85MQ2 2024: $557.1KQ3 2024: $320.0KQ4 2024: $800.3KQ1 2025: $527.7KQ2 2025: $2.38MQ3 2025: $798.7KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CERO and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 202511$798.7K
Q2 20258$2.38M
Q1 202515$527.7K
Q4 202421$800.3K
Q3 202418$320.0K
Q2 202415$557.1K
Q1 20249$4.85M
Q4 202310$7.49M
Q3 202310$7.33M
Q2 202313$10.6M
Q1 202317$12.5M
Q4 202246$101.1M
Q3 202266$153.0M
Q2 202254$144.5M
Q1 202245$137.2M
Q4 202136$104.2M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q1 2022.

Institutions holding CERO in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Saba Capital Management, L.P.1,132,426$11.3M0.15%+398,600+54.3%Added
Highbridge Capital Management LLC1,029,262$10.3M0.25%−4,688−0.5%Reduced
Cantor Fitzgerald, L. P.750,000$7.51M0.15%00.0%Unchanged
D. E. Shaw & Co., Inc.735,211$7.37M0.01%+125,423+20.6%Added
Marshall Wace, LLP638,195$6.40M0.01%+9,314+1.5%Added
Polar Asset Management Partners Inc.599,999$6.01M0.08%00.0%Unchanged
Periscope Capital Inc.599,700$6.01M0.16%+300+0.1%Added
Fir Tree Capital Management LP501,164$5.03M0.16%+250,998+100.3%Added
Linden Advisors LP500,000$5.01M0.05%00.0%Unchanged
HGC Investment Management Inc.500,000$5.00M0.30%00.0%Unchanged
Westchester Capital Management, LLC461,268$4.63M0.14%+461,268New
Atalaya Capital Management LP450,000$4.51M0.53%00.0%Unchanged
Wolverine Asset Management LLC404,576$4.05M0.05%+250,010+161.7%Added
Context Capital Management, LLC400,000$4.01M0.29%00.0%Unchanged
Radcliffe Capital Management, L.P.391,479$3.92M0.12%+81,291+26.2%Added
MMCAP International Inc. SPC370,000$3.71M0.30%−380,000−50.7%Reduced
CNH Partners LLC362,918$3.64M0.08%00.0%Unchanged
Vivaldi Asset Management, LLC352,600$3.53M0.25%+352,600New
Woodline Partners LP300,000$3.01M0.05%+275,000+1,100.0%Added
Berkley W R Corp296,730$2.97M0.15%00.0%Unchanged
CSS LLC276,745$2.77M0.13%00.0%Unchanged
HSBC Holdings PLC261,723$2.62M0.00%+261,723New
Alberta Investment Management Corp250,000$2.51M0.02%00.0%Unchanged
Cubist Systematic Strategies, LLC239,920$2.40M0.02%+239,920New
Millennium Management LLC221,180$2.22M0.00%+3,680+1.7%Added
Highland Capital Management Fund Advisors, L.P.217,482$2.18M0.19%00.0%Unchanged
UBS Oconnor LLC210,009$2.11M0.02%+210,009New
CVI Holdings, LLC206,487$2.07M0.15%00.0%Unchanged
Weiss Asset Management LP205,000$2.06M0.05%−261,723−56.1%Reduced
Hudson Bay Capital Management LP200,000$2.01M0.02%00.0%Unchanged
Sage Rock Capital Management LP183,998$1.84M0.36%+183,998New
Picton Mahoney Asset Management150,000$1.50M0.06%00.0%Unchanged
Janus Henderson Group PLC130,000$1.30M0.00%+130,000New
Barclays PLC106,300$1.06M0.00%00.0%Unchanged
Kim, LLC100,000$1.00M0.05%+100,000New
Tenor Capital Management Co., L.P.100,000$1.00M0.02%00.0%Unchanged
Bulldog Investors, LLP99,064$993.0K0.27%−10,426−9.5%Reduced
Schonfeld Strategic Advisors LLC94,997$952.0K0.01%+5,000+5.6%Added
Whitebox Advisors LLC50,000$501.0K0.02%00.0%Unchanged
Rivernorth Capital Management, LLC49,996$501.0K0.02%00.0%Unchanged
Centiva Capital, LP42,046$422.0K0.02%+42,046New
Magnetar Financial LLC41,100$412.0K0.00%+41,100New
Lynwood Capital Management Inc.34,615$347.0K0.39%+5,000+16.9%Added
Dark Forest Capital Management LP31,909$320.0K0.07%00.0%Unchanged
Sculptor Capital LP29,367$294.0K0.00%+1,729+6.3%Added
DuPont Capital Management Corp25,000$251.0K0.01%00.0%Unchanged
Crestline Management, LP25,000$251.0K0.03%+25,000New
Starboard Value LPSuperinvestorStarboard Value21,275$213.0K0.00%00.0%Unchanged
HRT Financial LP13,548$135.0K0.00%−140−1.0%Reduced
Deltec Asset Management LLC10,000$100.0K0.02%00.0%Unchanged
Segantii Capital Management Ltd10,000$100.0K0.00%00.0%Unchanged
Robinson Capital Management, LLC6,530$65.0K0.05%+6,530New
UBS Group AG600$6.00K0.00%+600New
Tower Research Capital LLC (TRC)216$2.00K0.00%+216New
Beryl Capital Management LLC0$00.00%−1,230,264−100.0%Sold out
Citadel Advisors LLC0$00.00%−750,000−100.0%Sold out
Spring Creek Capital LLC0$00.00%−100,000−100.0%Sold out
Old Mission Capital LLC0$00.00%−15,188−100.0%Sold out
Ancora Advisors, LLC0$00.00%−5,000−100.0%Sold out